GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Core EBITDA Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Core EBITDA Margin(%) | 28.56 | 24.01 | 24.73 | 21.20 | 19.14 |
What is the latest Core EBITDA Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Core EBITDA Margin |
|---|---|
| Mar2025 | 28.56 |
| Mar2024 | 24.01 |
| Mar2023 | 24.73 |
| Mar2022 | 21.20 |
| Mar2021 | 19.14 |
How is Core EBITDA Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Core EBITDA Margin | % Change | |
|---|---|---|---|
| Mar2025 | 28.56 | 18.95 | |
| Mar2024 | 24.01 | -2.91 | |
| Mar2023 | 24.73 | 16.65 | |
| Mar2022 | 21.2 | 10.76 | |
| Mar2021 | 19.14 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,090.8 Cr | -2.7% | -0.1% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.3% | 2.7% | 10% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -2.7% |
-0.1% |
9.4% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses